These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies. Chin BB; Wahl RL Gut; 2003 Jun; 52 Suppl 4(Suppl 4):iv23-9. PubMed ID: 12746265 [TBL] [Abstract][Full Text] [Related]
4. [Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)]. Bourguet P; Planchamp F; Monteil J; Metges JP; Mitry E; Tubiana-Mathieu N Bull Cancer; 2007 Feb; 94(2):212-8. PubMed ID: 17338096 [No Abstract] [Full Text] [Related]
5. [Role of positron emission tomography is the evaluation of digestive tract tumors]. Hustinx R; Paulus P; Daenen F; Detroz B; Honoré P; Jacquet N; Rigo P Rev Med Liege; 1999 Dec; 54(12):925-30. PubMed ID: 10686798 [TBL] [Abstract][Full Text] [Related]
6. The role of positron emission tomography in gastrointestinal imaging. Moadel RM; Blaufox MD; Freeman LM Gastroenterol Clin North Am; 2002 Sep; 31(3):841-61. PubMed ID: 12481734 [TBL] [Abstract][Full Text] [Related]
7. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms]. Bourguet P; Bull Cancer; 2003 Feb; 90 Spec No():S56-66. PubMed ID: 12739337 [No Abstract] [Full Text] [Related]
10. Newer radiological techniques in the diagnosis of gastrointestinal cancer. Dodd GD; Goldstein HM Clin Gastroenterol; 1976 Sep; 5(3):597-624. PubMed ID: 1022376 [No Abstract] [Full Text] [Related]
11. PET imaging in assessing gastrointestinal tumors. Hustinx R Radiol Clin North Am; 2004 Nov; 42(6):1123-39, ix. PubMed ID: 15488562 [TBL] [Abstract][Full Text] [Related]